Drug intelligence / Profile preview

BK6501

Development stage: Unknown
Lead developer: Research Foundation for Microbial Diseases of Osaka University
Modality: Vaccines & Immunotherapeutics
Administration: Intramuscular, Intranasal, Intradermal, Auricular, Infusion, Inhalation

Overview

BK6501 is an investigational influenza vaccine candidate being developed by The Research Foundation for Microbial Diseases of Osaka University (BIKEN). It is designed to prevent influenza infection by inducing protective immunity against the influenza virus. As of the latest clinical development updates, BK6501 is in Phase 1/2 clinical trials to evaluate its safety, tolerability, and immunogenicity in human subjects.

Targets

Flu (Influenza surface proteins)

Beyond the preview

Go deeper on BK6501.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BK6501.

Explore the full profile